A. A. M. Van Der Veldt - Department of Medical Oncology, Erasmus MC Cancer Institute

基本信息

浏览量：40

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 86 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

1110P Follow-up Brain Imaging in Patients with Melanoma Brain Metastasis and Immune Checkpoint Inhibitors

I. Ozdamar,S.H.A.E. Derks, L.S. Ho, E.L. van der Meer, K.A.T. Naipal,A. Joosse, M.J.A. de Jonge, M. Smits, M.J. van den Bent,J.L.M. Jongen,A.A.M. Van der Veldt

Annals of Oncology (2024)

引用0浏览0引用

1085P Adoptive Cell Therapy with TCR Gene-Engineered T Cells Directed Against MAGE-C2-positive Melanoma: an Ongoing Phase I Trial

B. van Dijk, C. Lamers,K. de Joode, M. de Beijer,C. Berrevoets,M. van Brakel, J. Tsui,K. Bezemer,S. de Wilde, M.J.A. de Jonge, S. Sleijfer,A.A.M. Van der Veldt,R. Debets

Annals of Oncology (2024)

引用0浏览0引用

LBA42 Distant Metastasis-Free Survival of Neoadjuvant Nivolumab Plus Ipilimumab Versus Adjuvant Nivolumab in Resectable, Macroscopic Stage III Melanoma: the NADINA Trial

M.W. Lucas, A.M. Menzies,M. Lopez-Yurda, R.A. Scolyer,B. van de Wiel,R.P.M. Saw,W. Van Houdt, N. Maher,A. Torres Acosta,M. Boers-Sonderen, G. Hospers,M.S. Carlino,J.W. de Groot, E. Kapiteijn,K. Suijkerbuijk, P. Rutkowski, S.K. Sandhu,A.A.M. Van der Veldt, G.V. Long, C.U. Blank

Annals of Oncology (2024)

引用0浏览0引用

1119P Genomic and Transcriptomic Predictors of Resistance to Anti-Pd1 Monotherapy in Patients with Advanced Melanoma

W. Wang, J.C. Janssen,K. de Joode,M. Aarts,M. Jalving,J.W. de Groot,H.M. Westgeest,K. Suijkerbuijk, J.B.A.G. Haanen,M. Labots,H.M.W. Verheul, P. Katsikis,A.A.M. Van der Veldt, H. van de Werken

Annals of Oncology (2024)

引用0浏览0引用

Randomized Phase II Dose Comparison LITESPARK-013 Study of Belzutifan in Patients with Advanced Clear Cell Renal Cell Carcinoma

N Agarwal,J Brugarolas, P Ghatalia, S George,J B Haanen,H Gurney, R Ravilla,A Van der Veldt,B Beuselinck,I Pokataev, B, M H Tuthill,D Vaena, F Zagouri, J Wu,R F Perini, Y Liu,J Merchan, M B Atkins

Annals of oncology official journal of the European Society for Medical Oncology (2024)

引用0浏览0WOS引用

1154P Thromboembolic Events in Patients with Melanoma Receiving Immune Checkpoint Inhibitors: Incidence and Risk Factors

D. van Dorst, M. M. Hofman,R. M. de Waal, E. Oomen-de Hoop,K. D. Joode,S. Bins,S. L. Koolen,A. Joosse,J. Versmissen,A. A. M. Van der Veldt,R. H. Mathijssen

Annals of Oncology (2023): S689-S689

引用0浏览0引用

Health-state utilities in long-term advanced melanoma survivors comparable with the general population

M. D. Egeler,L. V. van de Poll-Franse, R. Tissier,A. Rogiers,M. J. Boers-Sonderen,A. J. van den Eertwegh,G. A. Hospers,J. W. B. de Groot,M. J. B. Aarts,E. Kapiteijn,D. Piersma,G. Vreugdenhil,A. A. van der Veldt,K. P. M. Suijkerbuijk,B. Neyns, K. J. Janssen,C. U. Blank,V. P. Retèl,A. H. Boekhout

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitationno. 9 (2023): 2517-2525

引用0浏览0WOS引用

1095P Associations between baseline biomarkers and 3-year survival in the PRADO trial testing neoadjuvant ipilimumab and nivolumab in stage III melanoma

I. Reijers,P. Dimitriadis,A.M. Menzies,E. Kapiteijn,A.A.M. Van der Veldt,K.P.M. Suijkerbuijk,G.A.P. Hospers,W. Van Houdt,R. Saw,A. Broeks,S. Cornelissen,L. Grijpink-Ongering,T. Pennington, A. Colebatch,B. van de Wiel,R. Scolyer,A.C.J. van Akkooi,G.V. Long,C.U. Blank

Annals of Oncology (2023): S660-S660

引用0浏览0引用

Time Interval from Primary Melanoma to First Distant Recurrence in Relation to Patient Outcomes in Advanced Melanoma

Isabella A. J. van Duin,Sjoerd G. Elias, Alfonsus J. M. van den Eertwegh,Jan Willem B. de Groot,Willeke A. M. Blokx, Paul J. van Diest, Tim Leiner, Joost J. C. Verhoeff, Rik J. Verheijden,Olivier J. van Not,Maureen J. B. Aarts,Franchette W. P. J. van den Berkmortel,Christian U. Blank,John B. A. G. Haanen,Geke A. P. Hospers, Anna M. Kamphuis,Djura Piersma,Rozemarijn S. van Rijn,Astrid A. M. van Der Veldt,Gerard Vreugdenhil,Michel W. J. M. Wouters, Marion A. M. Stevense-den Boer,Marye J. Boers-Sonderen,Ellen Kapiteijn,Karijn P. M. Suijkerbuijk

Annals of Oncology（2022）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn